NDC 23155-240-33 - METOCLOPRAMIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 23155-240
- Requested NDC
- 23155-240-33
- Package NDCs from labels
- 23155-240-32, 23155-240-42, 23155-240-31, 23155-240-41, 23155-240-33, 23155-240-43
- Manufacturer
- Henry Schein, Inc.
- Effective date
- 2026-09-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metoclopramide Injection, USP 5mg/mL | Henry Schein, Inc. | 2026-09-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Rx only | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | AVET LIFESCIENCES PRIVATE LIMITED | Emcure Pharmaceuticals Limited | Maiva Pharma Private Limited | 2026-04-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Metoclopramide - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 23155-240-31 | Metoclopramide | 2 mL in 1 VIAL | INJECTION | 2 | 18 | |
| 23155-240-32 | Metoclopramide | 10 mL in 1 VIAL | INJECTION | 10 | 18 | |
| 23155-240-33 | Metoclopramide | 30 mL in 1 VIAL | INJECTION | 30 | 18 | |
| 23155-240-41 | Metoclopramide | 25 in 1 CARTON | INJECTION | 25 | 18 | |
| 23155-240-42 | Metoclopramide | 25 in 1 CARTON | INJECTION | 25 | 18 | |
| 23155-240-43 | Metoclopramide | 25 in 1 CARTON | INJECTION | 25 | 18 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 23155-240 | METOCLOPRAMIDE (METOCLOPRAMIDE HYDROCHLORIDE) INJECTION [HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC.] | 17 | Current NDC, Legacy NDC, 6 package rows | 20250501_50a3cf38-66dc-4fa5-8a45-adf959c987ab.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 23155-240-31 | ML - Milliliter | 23155-240 | 0760a73b-793f-4019-8c59-8c2f6223f358 | 1 | 2014-06-03 |
| 23155-240-41 | ML - Milliliter | 23155-240 | d6486bdb-89e5-4d97-8f90-c9d3bd70cff1 | 1 | 2014-06-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| METOCLOPRAMIDE HYDROCHLORIDE | ACTIVE INGREDIENT | W1792A2RVD | METOCLOPRAMIDE (METOCLOPRAMIDE HYDROCHLORIDE) INJECTION [HERITAGE PHARMACEUTICALS INC.] | 4 | |
| METOCLOPRAMIDE | ACTIVE MOIETY | L4YEB44I46 | METOCLOPRAMIDE (METOCLOPRAMIDE HYDROCHLORIDE) INJECTION [HERITAGE PHARMACEUTICALS INC.] | 4 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | METOCLOPRAMIDE (METOCLOPRAMIDE HYDROCHLORIDE) INJECTION [HERITAGE PHARMACEUTICALS INC.] | 4 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | METOCLOPRAMIDE (METOCLOPRAMIDE HYDROCHLORIDE) INJECTION [HERITAGE PHARMACEUTICALS INC.] | 4 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | METOCLOPRAMIDE (METOCLOPRAMIDE HYDROCHLORIDE) INJECTION [HERITAGE PHARMACEUTICALS INC.] | 4 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | METOCLOPRAMIDE (METOCLOPRAMIDE HYDROCHLORIDE) INJECTION [HERITAGE PHARMACEUTICALS INC.] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metoclopramide | METOCLOPRAMIDE HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 50a3cf38-66dc-4fa5-8a45-adf959c987ab | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | ANDA204756 23155-240-31 23155-240-41 23155-240-42 23155-240-43 23155-240-33 23155-240-32 23155-240 23155024033 311670 b5e5868d-a0b2-4983-8c72-08199013d64b 50a3cf38-66dc-4fa5-8a45-adf959c987ab W1792A2RVD |
| Sodium Chloride | SODIUM CHLORIDE | Sportpharm LLC | a2c111f6-74d5-4a5d-82ac-d0f237488cb8 | 2026-04-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Method Pharmaceuticals, LLC | 4b08859e-65bd-8255-e063-6394a90af614 | 2026-04-23 | Warnings | 451W47IQ8X |
| Metoclopramide | METOCLOPRAMIDE | Teva Parenteral Medicines, Inc. | cccf04bd-7463-40b8-a41f-cb1093c358d7 | 2026-04-22 | Boxed warning, Warnings, Adverse reactions | 311670 W1792A2RVD |
| Ringers | SODIUM CHLORIDE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | ICU Medical, Inc. | a926f913-18fa-4a3e-bfd6-210e1e427960 | 2026-04-20 | Warnings, Adverse reactions | 451W47IQ8X |
| Cardioforce II | ABROTANUM, BOLDO, CIMICIFUGA RACEMOSA, KALI PHOSPHORICUM, TARAXACUM OFFICINALE, CONVALLARIA MAJALIS, MAGNESIA SULPHURICA, OLEANDER, NATRUM MURIATICUM, BELLIS PERENNIS | BioActive Nutritional, Inc. | 733bbb26-7698-4a1b-9dc8-7e3490ffc92b | 2026-04-17 | Warnings | 451W47IQ8X |
| Thyroid HP | BARYTA CARBONICA, CALCAREA CARBONICA, FUCUS VESICULOSUS, IODIUM, NATRUM MURIATICUM, PULSATILLA, SPONGIA TOSTA, THYROIDINUM (SUIS) | BioActive Nutritional, Inc. | 3795820a-cf2a-4094-9a02-70e3757b7510 | 2026-04-17 | Warnings | 451W47IQ8X |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 99c6a1a9-cadf-435b-a332-ccc189afdfa9 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| Metoclopramide | METOCLOPRAMIDE | Teva Parenteral Medicines, Inc. | 5645a752-8868-4b51-8b59-48bb4276d763 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | 311670 W1792A2RVD |
| Anxiety Relief | ACONITUM NAPELLUS, ARGENTUM NITRICUM, ARSENICUM ALBUM, AURUM METALLICUM, GELSEMIUM SEMPERVIRENS, HYOSCYAMUS NIGER, IGNATIA AMARA, KALI CARBONICUM, MOSCHUS, NATRUM MURIATICUM, PIPER METHYSTICUM | NaturalCare | 9f982e89-655c-49be-85d8-4099a02ed021 | 2026-04-15 | Warnings | 451W47IQ8X |
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | 451W47IQ8X |
| METOCLOPRAMIDE | METOCLOPRAMIDE | HF Acquisition Co LLC, DBA HealthFirst | 4046830f-4b87-5e6e-e063-6394a90aeeb8 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | 311670 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Hospira, Inc. | 373ba08b-33ad-49fc-28a7-928e89a65314 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | 311670 W1792A2RVD |
| SODIUM CHLORIDE 1 GRAM | SODIUM CHLORIDE | Gendose Pharmaceuticals, LLC | ce988ae5-61c6-4324-90e1-a94c8a54d0d0 | 2026-04-13 | Warnings | 451W47IQ8X |
| Quantum Resonance | ALCOHOLUS, ALUMINA SILICATA, ANACARDIUM ORIENTALE, AQUA MARINA, BAPTISIA TINCTORIA, CANDIDA ALBICANS, COLLAGEN, DNA, LAVANDULA OFFICINALIS, MEDULLA OSSIS SUIS, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NUX MOSCHATA, PHOSPHORUS, QUARTZ, SILICEA, TELA ARANEA, VALERIANA OFFICINALIS, VISCUM ALBUM | Deseret Biologicals, Inc. | f94a10bd-1c40-42c7-b458-b58070614549 | 2026-04-10 | Warnings | 451W47IQ8X |
| Quantum Resonance | ALCOHOLUS, ALUMINA SILICATA, ANACARDIUM ORIENTALE, AQUA MARINA, BAPTISIA TINCTORIA, CANDIDA ALBICANS, COLLAGEN, DNA, LAVANDULA OFFICINALIS, MEDULLA OSSIS SUIS, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NUX MOSCHATA, PHOSPHORUS, QUARTZ, SILICEA, TELA ARANEA, VALERIANA OFFICINALIS, VISCUM ALBUM | Deseret Biologicals, Inc. | 1467111a-bef6-473d-b7f2-3309a9bb72ce | 2026-04-10 | Warnings | 451W47IQ8X |
| H-Focus Formula | AGNUS CASTUS, AVENA SATIVA, BARYTA CARBONICA, IGNATIA AMARA, LYCOPODIUM CLAVATUM, NATRUM CARBONICUM, NATRUM MURIATICUM, PHOSPHORICUM ACIDUM, SILICEA, ZINCUM METALLICUM | Healing Natural Oils LLC | 4ee42911-3064-7f55-e063-6294a90abcc7 | 2026-04-07 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.